Johnson & Johnson (JNJ) focuses on its Medical Devices business restructuring to attain a profitable and efficient business structure. The above diagram shows the key growth strategies that are driving these restructuring efforts, which are expected to yield around $800 million–$1 billion in annual savings. The majority of these savings are expected to be realized by the end of 2018. Over the last few quarters, Johnson & Johnson expects to witness a marked above-market performance growth in its Medical Device business. The company is keen on making bolt-on acquisitions and expanding into attractive markets for the segment's growth. Johnson & Johnson believes that the cardiovascular space is a potential growth area in businesses such as the Structural Heart business. The company already has a strong presence in the Electrophysiology business in the cardiovascular market.